EquityFlow
›
Companies
› Biodol Therapeutics
Biodol Therapeutics
Biotech
· Montarnaud, FR
Developer of next-generation chronic-pain treatments.
Funding history
Date
Round
Amount
May 2024
Grant
Biodol Therapeutics, a French chronic-pain biotech, was awarded EUR7M by BPI France for first-in-human trials.
$7.6M
Investors
BPI France
V-Bio Ventures
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →